Accuracy of the 6-Minute Walk Test for Assessing Functional Capacity in Patients With Heart Failure With Preserved Ejection Fraction and Other Chronic Cardiac Pathologies: Results of the ExIC-FEp Trial and a Meta-Analysis
Sports Medicine - Open,
Journal Year:
2024,
Volume and Issue:
10(1)
Published: June 18, 2024
Abstract
Background
Heart
diseases,
particularly
heart
failure,
significantly
impact
patient
quality
of
life
and
mortality
rates.
Functional
capacity
assessment
is
vital
for
predicting
prognosis
risk
in
these
patients.
While
the
cardiopulmonary
exercise
test
considered
gold
standard,
6-minute
walk
has
emerged
as
a
more
accessible
alternative.
However,
screening
accuracy
optimal
cut-off
points
detecting
severely
reduced
functional
cardiac
pathologies,
including
failure
with
preserved
ejection
fraction,
are
unclear.
The
study
aimed
to
analyse
diagnostic
capacity,
defined
VO
2max
<
14
ml/kg/min,
compared
participants
fraction
using
data
from
“Ejercicio
en
Insuficiencia
Cardiaca
con
Fracción
de
Eyección
Preservada”
(ExIC-FEp)
trial;
compare
results
previous
studies
investigating
assessing
other
chronic
pathologies
through
meta-analysis.
Results
ExIC-FEp
trial
involved
22
who
were
not
treated
beta-blockers,
test,
specifically
2max,
reference
test.
had
sensitivity
70%,
specificity
80%,
an
area
under
curve
76%
trial.
Five
included
meta-analysis
showing
79%,
78%,
85%.
Conclusion
In
conclusion,
holds
promise
tool
ml/kg/min
point.
It
demonstrates
moderate
good
accuracy.
regardless
aetiology,
Trial
Registration
NCT05726474.
Registered
16
February
2023,
https://clinicaltrials.gov/study/NCT05726474
.
Language: Английский
Cancer-Therapy-Related Cardiac Dysfunction: Latest Advances in Prevention and Treatment
Carla Contaldi,
No information about this author
Carmine D’Aniello,
No information about this author
Domenico Panico
No information about this author
et al.
Life,
Journal Year:
2025,
Volume and Issue:
15(3), P. 471 - 471
Published: March 15, 2025
The
increasing
efficacy
of
cancer
therapies
has
significantly
improved
survival
rates,
but
it
also
highlighted
the
prevalence
cancer-therapy-related
cardiac
dysfunction
(CTRCD).
This
review
provides
a
comprehensive
overview
identification,
monitoring,
and
management
CTRCD,
condition
resulting
from
several
treatments,
such
as
anthracyclines,
HER2-targeted
therapies,
target
radiotherapy.
paper
includes
discussion
mechanisms
CTRCD
associated
with
various
treatments.
Early
detection
through
serum
biomarkers
advanced
imaging
techniques
is
crucial
for
effective
monitoring
risk
stratification.
Preventive
strategies
include
pharmacological
interventions
ACE
inhibitors/angiotensin
receptor
blockers,
beta-blockers,
statins.
Additionally,
novel
agents
like
sacubitril/valsartan,
sodium-glucose
co-transporter
type
2
inhibitors,
vericiguat
show
promise
in
managing
left
ventricular
dysfunction.
Lifestyle
modifications,
including
structured
exercise
programs
optimized
nutritional
strategies,
further
contribute
to
cardioprotection.
latest
treatments
both
asymptomatic
symptomatic
across
its
stages
are
discussed.
Emerging
technologies,
genomics,
artificial
intelligence,
biomarkers,
gene
therapy,
paving
way
personalized
approaches
prevention
treatment.
These
advancements
hold
great
improving
long-term
outcomes
patients
by
minimizing
cardiovascular
complications.
Language: Английский
Effects of sex and obesity on immune checkpoint inhibition-related cardiac systolic dysfunction in aged mice
Nabil V. Sayour,
No information about this author
Dániel Kucsera,
No information about this author
Abdulaziz AlHaddad
No information about this author
et al.
Basic Research in Cardiology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 8, 2024
Despite
accumulating
data
on
underlying
mechanisms,
the
influence
of
sex
and
prevalent
cardio-metabolic
co-morbidities
manifestation
severity
immune
checkpoint
inhibitor
(ICI)-induced
cardiotoxicity
has
not
been
well
defined.
To
elucidate
whether
affect
ICI-induced
cardiotoxicity,
we
randomized
17-month-old
male
female
mice
to
receive
control
diet
(CON)
or
high-fat
(HFD)
+
L-NAME-a
well-established
mouse
model
co-morbidities-for
17
weeks
(n
=
5-7),
evaluated
markers
T-cell
function
in
spleen.
As
expected,
HFD
L-NAME
significantly
increased
body-
heart
weight,
serum
cholesterol
levels,
caused
no
systolic
dysfunction,
however,
led
diastolic
cardiomyocyte
hypertrophy,
fibrosis
only
males
compared
corresponding
CON.
Western
blot
analyses
splenic
protein
levels
showed
differential
expression
depending
co-morbidities,
suggesting
exhaustion
both
sexes
L-NAME,
but
more
pronounced
males.
In
a
sub-study
with
similar
setup,
tested
cardiotoxic
manifestations
ICI
by
treating
anti-PD-1
monoclonal
antibody
(ICI)
for
last
2
administration
5-7).
After
treatment,
cardiac
functions
decreased
CON,
groups
baseline
(before
administration).
conclusion,
this
exploratory
study
using
aged
mice,
describe
first
time
that
ICI-related
dysfunction
is
diminished
when
obesity
hypercholesterolemia
are
present,
possibly
due
obesity-related
exhaustion.
Language: Английский
Cardiovascular mortality in people with cancer compared to the general population: A systematic review and meta‐analysis
Cancer Medicine,
Journal Year:
2024,
Volume and Issue:
13(15)
Published: Aug. 1, 2024
Abstract
Background
Cardiovascular
disease
(CVD)
is
the
leading
cause
of
non‐cancer
death
in
cancer
survivors,
but
risk
CVD
varies
between
cancers.
Objectives
To
synthesise
available
evidence
on
patterns
and
magnitude
mortality
risk.
Methods
A
systematic
search
Medline
(OVID),
CINAHL
Scopus
databases
from
01‐January‐2000
to
16‐July‐2023
studies
people
with
cancer,
reporting
population
compared
a
reference
(e.g.
general
population)
as
standardised
ratios
(SMR).
Meta‐analysis
SMRs
across
types
were
pooled
using
random‐effects
model
allow
for
heterogeneity
true
effect
size
studies.
Results
We
identified
136
16
countries.
Sample
sizes
ranged
157
7,529,481.
The
majority
(
n
=
98;
72%)
conducted
United
States,
followed
by
Europe
22;
16%).
most
common
cancers
studied
gastrointestinal
34
studies),
haematological
31)
breast
29).
total
876
extracted
diverse
conditions.
Of
those,
(535;
61%)
indicated
an
increased
(SMR
>1),
109
(12%)
lower
<1)
232
(27%)
equivalent
(95%
CI
SMR
included
1)
population.
meta‐analysis
all
reported
showed
1.55,
95%
1.40–1.72)
survivors
varied
conditions
1.36
1.29–1.44)
heart
diseases
1.56
1.39–1.76)
cerebrovascular
diseases.
types,
ranging
1.14
1.04–1.25)
testicular/germ
cell
tumours
2.82
2.20–3.63)
brain/central
nervous
system
tumours.
Conclusions
Cancer
are
at
premature
population,
type
CVD.
Future
research
should
focus
understanding
mechanisms
behind
develop
appropriate
interventions.
Language: Английский
Cardioprotection of voluntary exercise against breast cancer-induced cardiac injury via STAT3
Basic Research in Cardiology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 19, 2024
Language: Английский
Prehabilitation for patients undergoing neoadjuvant therapy prior to cancer resection: a systematic review and meta-analysis
Ye Chen,
No information about this author
Raquel Sebio,
No information about this author
Edgar Iglesias-Garcia
No information about this author
et al.
Supportive Care in Cancer,
Journal Year:
2024,
Volume and Issue:
32(11)
Published: Oct. 28, 2024
Language: Английский
A Lived Experience of an Accredited Exercise Physiologist with Breast Cancer—A Unique Perspective of Exercise
Journal of Clinical Exercise Physiology,
Journal Year:
2024,
Volume and Issue:
13(3), P. 100 - 110
Published: Aug. 23, 2024
Language: Английский
Left ventricular ejection time: its relation to left ventricular systolic function and functional capacity in cardiomyopathic patients
Eman S. El Shahawy,
No information about this author
Asmaa A. Hassan
No information about this author
Al-Azhar Assiut Medical Journal,
Journal Year:
2024,
Volume and Issue:
22(2), P. 118 - 126
Published: April 1, 2024
Background
and
aim
Left
ventricular
ejection
time
(LVET)
was
used
to
evaluate
left
function.
Transthoracic
echocardiogram
done,
parameters
of
LV
systolic
function
by
utilizing
tissue
Doppler
imaging
two-dimensional
strain
were
obtained.
Moreover,
the
New
York
Heart
Association
(NYHA)
functional
class
6
min
walk
test
(6MWT)
investigated
intending
detect
LVET
value
in
detection
dysfunction
patients
with
dilated
cardiomyopathy
(DCM)
its
relation
a
capacity
assess
clinical
severity
heart
failure.
Patients
methods
The
enrolled
131
cases
(101
myopathic
30
case
as
control).
All
do
complete
transthoracic
dimensions,
volumes,
Parameters
compared
both
groups.
calculated,
compared,
correlated
function,
NYHA
class,
6MWT.
Results
volumes
DCM
significantly
elevated
(
P
<0.001),
while
their
reduced.
Additionally,
cardiomyopathic
group
revealed
significant
reduction
comparison
control
=0.002).
correlates
[LVEF
M-mode
r
=0.01),
LVEF
=0.17),
global
longitudinal
=0.09),
velocity
=0.20)].
Furthermore,
connected
6MWT
=−0.06,
<0.0001,
=0.04,
=0.01,
respectively).
Conclusions
In
individuals
having
DCM,
is
simple
valuable
measure
diagnose
well
it
has
potential
implications
for
assessing
Language: Английский